Objective: Multiple Sclerosis (MS) is a neurological condition which widely affects people 50-
60 years of age. While clinical presentations of MS are highly heterogeneous, mobility …

Objective: Multiple sclerosis (MS) is a chronic neurological condition of the central nervous
system leading to various physical, mental and psychiatric complexities. Mobility limitations …

In multiple sclerosis (MS), gait impairment is one of the most prominent symptoms. For a
sensitive assessment of pathological gait patterns, a comprehensive analysis and …

Background Using embedded sensors, instrumented walkways provide clinicians with
important information regarding gait disturbances. However, because raw data are …

Objective: Mobility assessment is critical in the clinical management of people with Multiple
Sclerosis (pwMS). Instrumented gait analysis provides a plethora of metrics for quantifying …

This study examined the effectiveness of av ision-based framework for m ultiple s clerosis
(MS) and Parkinson's disease (PD) gait dysfunction prediction. We collected gait video data …

Background: The timed 25-foot walk (T25FW) is widely used as a clinic performance
measure, but has yet to be directly validated against gait speed in the home environment …

Most multiple sclerosis (MS) patients eventually suffer from mobility impairment, and thus it is
critical that walking disability in MS be accurately assessed. The six-minute walk test …

Gait speed is a powerful clinical marker for mobility impairment in patients suffering from
neurological disorders. However, assessment of gait speed in coordination with delivery of …

Falls are a significant problem for persons with multiple sclerosis (PwMS). Yet fall prevention
interventions are not often prescribed until after a fall has been reported to a healthcare …